In the era of the universal use of statins dyslipidemia's are still common in heart transplant recipients: a cross-sectional study
M Zakliczynski, J Boguslawska, E Wojniak… - Transplantation …, 2011 - Elsevier
BACKGROUND: Statins are used in orthotopic heart transplant (OHT) recipients to avoid
acute rejection episodes (ARE) during the first year after surgery and coronary vasculopathy
(CAV) thereafter as established in prospective randomized trials, yielding the grounds for the
universal use of this group of drugs. The aim of the study was to describe the occurrence of
dyslipidemias among OHT recipients after introduction of guidelines suggesting the use of
statins in all individuals able to tolerate this therapy. METHODS: Medical records of all OHT …
acute rejection episodes (ARE) during the first year after surgery and coronary vasculopathy
(CAV) thereafter as established in prospective randomized trials, yielding the grounds for the
universal use of this group of drugs. The aim of the study was to describe the occurrence of
dyslipidemias among OHT recipients after introduction of guidelines suggesting the use of
statins in all individuals able to tolerate this therapy. METHODS: Medical records of all OHT …